Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model

SAL200 is derived from a phage endolysin and is a novel candidate drug for the treatment of Staphylococcus aureus infection. We investigated the efficacy of the recombinant endolysin SAL200 in a lethal murine pneumonia model. Lethal pneumonia was established by intranasally administering a methicill...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Bae, Ji Yun, Jun, Kang Il, Kang, Chang Kyung, Song, Kyoung-Ho, Choe, Pyoeng Gyun, Bang, Ji-Hwan, Kim, Eu Suk, Park, Sang Won, Kim, Hong Bin, Kim, Nam-Joong, Park, Wan Beom, Oh, Myoung-don
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2019
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437543/
https://ncbi.nlm.nih.gov/pubmed/30670417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02009-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires